SBIR Phase I: Tagging and Authentication Technology for Vaccines (COVID-19) — NSF Award to BALLYDEL TECHNOLOGIES INC. (DE, $256,00
The broader impact /commercial potential of this Small Business Innovation Research (SBIR) Phase I project is the development of a state-of-the-art, counterfeit-proof security technology to enable vaccine manufacturers to tag, track, and authenticate vaccine products throughout the supply chain. The tagging process wil
| Award title | SBIR Phase I: Tagging and Authentication Technology for Vaccines (COVID-19) |
|---|---|
| Award ID | 2111844 |
| Awardee | BALLYDEL TECHNOLOGIES INC. |
| City | WILMINGTON |
| State | DE |
| Amount obligated | $256,000 |
| Principal investigator | Brendan DeLacy |
| Program | SBIR Phase I |
| Start date | 05/15/2021 |
| Abstract | The broader impact /commercial potential of this Small Business Innovation Research (SBIR) Phase I project is the development of a state-of-the-art, counterfeit-proof security technology to enable vaccine manufacturers to tag, track, and authenticate vaccine products throughout the supply chain. The tagging process will be amenable to its integration into a scalable glass vial manufacturing process. Digital information such as product, lot number, expiry, etc. may be embedded into the tags, if d |
| Source | NSF Awards |
$799/mo
Try NSFGrants →